Inventor · disambiguated record
Brian Hearn
Also filed as: HEARN BRIAN · HEARN BRIAN R
11 granted patents·6 pending applications·50 citations·filing 2005–2025
87Inventor score
Files withPROLYNX LLC8UNIV CALIFORNIA3BRISTOL MYERS SQUIBB CO2KOSAN BIOSCIENCES INC2AURIGENE ONCOLOGY LTD1
Top patents by PatentIndex Score
17 records- 0189US9708247B2Modulators of the eIF2alpha pathwayUNIV CALIFORNIA·Filed 2015·Granted Jul 18, 2017·14 cites·6 claims
- 0288US7541330B2Conjugates with reduced adverse systemic effectsKOSAN BIOSCIENCES INC·Filed 2005·Granted Jun 2, 2009·5 cites·1 claims
- 0388US7446196B2Leptomycin compoundsKOSAN BIOSCIENCES INC·Filed 2005·Granted Nov 4, 2008·16 cites·4 claims
- 0486US7655808B2Leptomycin compoundsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Feb 2, 2010·9 cites·19 claims
- 0584US10343981B2Modulators of the eIF2alpha pathwayUNIV CALIFORNIA·Filed 2017·Granted Jul 9, 2019·6 cites·7 claims
- 0675US2023321286A1Protocol for minimizing toxicity of combination dosages and imaging agent for verificationPROLYNX LLC·Filed 2023·Application pending·0 cites
- 0774US12428379B2Acylsulfonamide KAT6A inhibitorsOLEMA PHARMACEUTICALS INC·Filed 2024·Granted Sep 30, 2025·0 cites·27 claims
- 0870US2009181039A1Conjugates with reduced adverse systemic effectsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 0969US11220477B2Modulators of the eIF2alpha pathwayUNIV CALIFORNIA·Filed 2019·Granted Jan 11, 2022·0 cites·4 claims
- 1061US12364771B2Conjugation linkersPROLYNX LLC·Filed 2020·Granted Jul 22, 2025·0 cites·11 claims
- 1158US10086049B2Conjugates of somatostatin analoguesPROLYNX LLC·Filed 2014·Granted Oct 2, 2018·0 cites·1 claims
- 1257US2025059204A1Fused benzoisoxazolyl compounds as kat6a inhibitorsAURIGENE ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 1356US2024041982A1Extended release hydrogel conjugates of c-natriuretic peptidesPROLYNX LLC·Filed 2021·Application pending·0 cites
- 1452US12472261B2Conjugated inhibitors of DNA damage responsePROLYNX LLC·Filed 2020·Granted Nov 18, 2025·0 cites·16 claims
- 1551US10413594B2Conjugates of somatostatin analoguesPROLYNX LLC·Filed 2018·Granted Sep 17, 2019·0 cites·5 claims
- 1651US2025312498A1Protocol for minimizing toxicity of combination dosages and imaging agent for verificationPROLYNX LLC·Filed 2025·Application pending·0 cites
- 1738US2020164083A1Extended release conjugates of exenatide analogsPROLYNX LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian Hearn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →